Boothbay Fund Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1231 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1201 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1300 |
|
|
2023
Q2 | – | Sell |
-175,860
| Closed | -$742K | – | 1541 |
|
|
2023
Q1 | $742K | Buy |
175,860
+123,618
| +237% | +$522K | 0.02% | 934 |
|
|
2022
Q4 | $859K | Sell |
52,242
-34,669
| -40% | -$570K | 0.02% | 798 |
|
|
2022
Q3 | $1.11M | Sell |
86,911
-41,372
| -32% | -$528K | 0.03% | 723 |
|
|
2022
Q2 | $1.5M | Buy |
+128,283
| New | +$1.5M | 0.04% | 587 |
|
|
2021
Q2 | – | Sell |
-19,495
| Closed | -$275K | – | 1656 |
|
|
2021
Q1 | $275K | Buy |
19,495
+1,628
| +9% | +$23K | 0.01% | 1016 |
|
|
2020
Q4 | $202K | Buy |
17,867
+5,775
| +48% | +$65.3K | 0.01% | 940 |
|
|
2020
Q3 | $160K | Buy |
12,092
+81
| +0.7% | +$1.07K | 0.01% | 831 |
|
|
2020
Q2 | $129K | Buy |
+12,011
| New | +$129K | 0.01% | 728 |
|